Generic placeholder image

Anti-Infective Agents


ISSN (Print): 2211-3525
ISSN (Online): 2211-3533

Review Article

Cytomegalovirus Replication Steps and the Actions of Antiviral Drugs

Author(s): Ashwaq Ahmed Abdullah*, Krishnan Nair Balakrishnan, Jamilu Abubakar Bala, Faez Firdaus Jesse Abdullah, Zeenatul Allaudin Nazariah, Rasedee Abdullah, Mohamed Mustapha Noordin and Mohd-Azmi Mohd-Lila*

Volume 16, Issue 2, 2018

Page: [80 - 95] Pages: 16

DOI: 10.2174/2211352516666180619155021

Price: $65


Human cytomegalovirus (HCMV) is a beta herpesvirus that inflicts an active infection in the fetus and immunosuppressive patients. The virus encodes many proteins that work together with cellular factors to achieve virus replication. In addition to vaccines, antiviral drugs can be deployed to manipulate how the virus replicates and minimize its pathogenicity. The five antiviral drugs approved by the Food and Drug Administration (FDA) have shown adverse reactions and the antiviral drug resistance were reported. Hence, this warrants the need for urgent development of a novel antiviral drug. Detailed understanding of the virus replication steps and how cellular signals interact with these steps will be key for pharmacological developments of for anti HCMV drugs. This review summarized all the drugs that target the virus proteins and cell signals that mediate CMV replication.

Keywords: Cytomegalovirus, immunosuppressive patients, congenital infection, ganciclovir, herpesvirus, fomivirsen.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy